Welcome to our dedicated page for QT IMAGING HOLDINGS SEC filings (Ticker: QTI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on QT IMAGING HOLDINGS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into QT IMAGING HOLDINGS's regulatory disclosures and financial reporting.
QT Imaging Holdings, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on July 28, 2026. Of the 13,768,903 shares of common stock outstanding and entitled to vote, 8,698,769 shares were represented, constituting a quorum.
Stockholders elected Professor Zeev Weiner and Bryan Timm as Class II directors to serve until the 2029 Annual Meeting. They also ratified BPM LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026 and approved an amendment to the 2024 Equity Incentive Plan to increase shares authorized and reserved for issuance.
QT Imaging Holdings is asking stockholders to vote at a virtual annual meeting on July 28, 2026 to elect two Class II directors, ratify BPM LLP as auditor for 2026, and approve an amendment to its 2024 Equity Incentive Plan. The plan amendment would increase shares of common stock reserved for equity awards from 1,827,278 by 550,900 shares (4% of currently issued and outstanding common stock) to 2,378,178. As of the June 23, 2026 record date, 13,768,903 common shares were outstanding. The proxy also highlights 2025 results: revenue rose to $18.9 million, above $18.0 million guidance and up 288% from $4.9 million in 2024, with 40 breast scanners shipped versus 12 in 2024, a 45% gross margin, operating expenses of $13.0 million versus $14.8 million, and a net loss of $21.1 million, or $2.01 per share. Net cash used in operating activities improved to $9.0 million from $10.0 million. The company raised $18.2 million in an October 2025 private placement, completed a 3:1 reverse stock split, uplisted to Nasdaq, and signed exclusive distribution agreements in Saudi Arabia and the UAE.
QT Imaging Holdings, Inc. is soliciting proxies for its virtual 2026 Annual Meeting on July 28, 2026. Stockholders of record as of June 23, 2026 may vote on election of two Class II directors, ratification of BPM LLP as auditor, and a Plan Amendment to increase shares reserved under the 2024 Equity Incentive Plan by 550,900 shares to 2,378,178, leaving 687,637 shares available for issuance if approved. The proxy statement discloses fiscal 2025 results: revenue of $18.9M (reported 288% growth vs. $4.9M in 2024), gross margin of 45%, operating expenses of $13.0M, and a net loss of $21.1M ( $2.01 per share). The company highlights a $18.2M private placement in October 2025, a 3:1 reverse stock split effective October 23, 2025, subsequent Nasdaq uplisting, and new exclusive distribution agreements in Saudi Arabia and the UAE.
QT Imaging Holdings, Inc. completed an underwritten public offering of 1,200,000 common shares and 800,000 pre-funded warrants for gross proceeds of $10 million, generating estimated net proceeds of about $9 million. The common shares were priced at $5.00 per share and the pre-funded warrants at $4.9999 each, with a nominal exercise price of $0.0001 per warrant share. All securities were sold by the company under an effective Form S-3 shelf registration, and the deal closed on May 18, 2026. The company plans to use the funds for working capital and general corporate purposes. Officers, directors and certain stockholders agreed to 90-day lock-ups, while the company agreed to 60-day restrictions on new equity issuance and a 180-day ban on variable rate transactions, subject to specified exceptions.
QT Imaging Holdings is offering $9,999,920 of securities consisting of 1,200,000 shares of common stock and pre-funded warrants to purchase up to 800,000 shares of common stock.
The public offering price is $5.00 per share (pre-funded warrant price equals share price minus $0.0001). Underwriting discounts total $699,994.40, and estimated net proceeds to the company are approximately $9.0 million before expenses. The company reported 12,042,500 shares outstanding as of May 14, 2026, and would have approximately 13,242,500 shares outstanding after the offering assuming none of the pre-funded warrants are exercised.
QT Imaging Holdings, Inc. reported sharply higher revenue and a smaller loss for the quarter ended March 31, 2026. Revenue rose to $6.5 million from $2.8 million a year earlier, driven almost entirely by product sales in the United States.
Gross profit increased to $2.7 million, but higher research and development plus selling, general and administrative expenses pushed the operating loss to $2.3 million. Net loss narrowed to $3.4 million from $11.1 million, helped by lower other expenses.
Cash and cash equivalents were $6.9 million, with cash used in operating activities of $3.7 million in the quarter. Total liabilities were $18.2 million and stockholders’ equity fell to $3.8 million from $6.4 million, reflecting ongoing losses and fair value changes in warrant and earnout liabilities.
The company highlighted distribution agreements with minimum order quantities that it believes, together with the Lynrock Lake Term Loan (now maturing in 2029 at 12% interest), PIPE financings, and expected MOQ-related revenue, will fund its operating plan for at least the next 12 months.
QT Imaging Holdings reported strong first quarter 2026 growth, with revenue of $6.5 million, up 133% from $2.8 million a year earlier, driven by shipments of 13 Breast Acoustic CT scanners versus six in the prior-year period.
Gross margin was 41% compared with 65%, reflecting mix effects, while operating expenses rose to $5.0 million from $2.9 million, leading to a net loss of $3.4 million, a notable improvement from $11.1 million. Cash, restricted cash, and cash equivalents were $7.0 million as of March 31, 2026.
The company extended the maturity of its senior secured term loan to March 31, 2029 and increased the interest rate to 12.0% per annum. It also secured a dedicated Category III CPT code effective January 1, 2027, obtained FDA 510(k) clearance for scanner enhancements, and reaffirmed 2026 revenue guidance of approximately $39 million supported by minimum order commitments and a multiyear UAE distribution agreement totaling more than $24 million in scanner revenue.
QT Imaging Holdings, Inc. Schedule 13G/A shows Alta Partners LLC reports beneficial ownership of 540,842 shares of Common Stock, representing 4.3% of the class; these shares are described as issuable upon exercise of warrants. The filing is signed by Steven Cohen as Managing Member on 05/08/2026.